The American Journal of Surgery
Volume 198, Issue 4 , Pages 500-504 , October 2009

Is there concordance of invasive breast cancer pathologic tumor size with magnetic resonance imaging?

Received 24 March 2009 ,Revised 6 July 2009

References 

  1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241
  2. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227
  3. Amano G, Ohuchi N, Ishibashi T, et al. Correlation of three-dimensional magnetic resonance imaging with precise histopathological map concerning carcinoma extension in the breast. Breast Cancer Res Treat. 2000;60:43–55
  4. Hata T, Takahashi H, Wataanabe K, et al. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. J Am Coll Surg. 2004;198:190–197
  5. Boetes C, Veltman V, van Die L, et al. The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat. 2004;2773:1–7
  6. Onesti JK, Mangus BE, Helmer SD, et al. Breast cancer tumor size: correlation between magnetic resonance imaging and pathology measurements. Am J Surg. 2008;196:844–850
  7. Greenstein SO, Schnall MD, Livolsi VA, et al. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology. 1994;190:485–493
  8. Cheung YC, Wan YL, Lo YF, et al. Preoperative magnetic resonance imaging evaluation for breast cancers after sonographically guided core-needle biopsy: a comparison study. Ann Surg Oncol. 2004;11:756–761
  9. Blair S, Mcelroy M, Middleton MS, et al. The efficacy of breast MRI in predicting breast conservation therapy. J Surg Oncol. 2006;94:220–225
  10. Thibault FN, Meunier M, El Khoury C, et al. MRI for surgical planning in patients with breast cancer who undergo preoperative chemotherapy. AJR Am J Roentgenol. 2004;183:1159–1168
  11. Partridge SC, Gibbs JE, Lu Y, et al. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol. 2002;179:1193–1199
  12. Kim DY, Moon WK, Cho N, et al. MRI of the breast for the detection and assessment of the size of DCIS. Korean J Radiol. 2007;8:32–39
  13. Kuroki Y, Nawano S, Hasebe T, et al. Efficacy of MR mammography (MRM) in providing preoperative locoregional information on breast cancer: correlation between MRM and histologic findings. Magn Reson Medical Sciences. 2002;1:73–80
  14. Schouten van der Velden AP, Boetes C, Bult P, et al. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast cancer. Am J Surg. 2006;192:172–178
  15. Kepple J, Layeeque R, Klimberg VS, et al. Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. Am J Surg. 2005;190:623–627
  16. Mumtaz H, Hall-Craggs MA, Davidson T, et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol. 1997;169:417–424
  17. Rodenko GN, Harms SE, Pruneda JM, et al. MR imaging in the management before surgery of lobular carcinoma of the breast, a correlation with pathology. AJR Am J Roentgenol. 1996;167:1415–1419

PII: S0002-9610(09)00407-3

doi: 10.1016/j.amjsurg.2009.07.012

The American Journal of Surgery
Volume 198, Issue 4 , Pages 500-504 , October 2009

Article Tools

* Image Usage & Resolution